Redefining seropositive rheumatoid arthritis: Clinical implications of anti-carbamylated protein on remission, radiographic damage and quality of life

Ann Acad Med Singap. 2024 Jan 30;53(1):60-62. doi: 10.47102/annals-acadmedsg.2023112.
No abstract available

Keywords: anti-carbamylated protein antibody; disease activity; early rheumatoid arthritis; functional disability; radiographic damage; remission.

Publication types

  • Letter

MeSH terms

  • Adult
  • Antirheumatic Agents / therapeutic use
  • Arthritis, Rheumatoid* / drug therapy
  • Autoantibodies / blood
  • Female
  • Humans
  • Male
  • Middle Aged
  • Protein Carbamylation
  • Quality of Life*
  • Radiography / methods
  • Remission Induction

Substances

  • Autoantibodies
  • Antirheumatic Agents